Dose escalation effectiveness and tolerability of paroxetine in patients with burning mouth syndrome and depressive conditions

Objective null To evaluate gradual dose escalation and tolerability of paroxetine in patients with burning mouth syndrome (BMS). null null null Methods null This 12-week, open-label, non-comparative, prospective study involved 43 subjects with depressive condition. The initial dosage of paroxetine was 10 mg/day, but was raised to 20 mg/day and 30 mg/day if efficacy was not sufficient. Pain was assessed using the visual analog scale (VAS) at...